Hodgkin lymphoma: open trials in South Korea

• NCT06788509

  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Trial Treatment · Phase 1 · Janssen Research & Development, LLC

  Severance Hospital, Yonsei University Health System, Seoul

  Registry updated 2026-11-04

• NCT07519772

  A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  The Catholic University of Korea, Yeouido St. Mary's Hospital (Site 0801), Seoul · Seoul National University Hospital (Site 0800), Seoul

  Registry updated 2026-10-29

• NCT06526793

  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Trial Treatment · Phase 2 · AstraZeneca

  Seoul

  Registry updated 2026-10-14

• NCT06137144

  AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  Trial Treatment · Phase 1/2 · AstraZeneca

  Seoul

  Registry updated 2026-10-13

• NCT06806033

  Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

  Trial Treatment · Phase 2 · Hoffmann-La Roche

  Seoul National University Bundang Hospital, Seongnam-si · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul

  Registry updated 2026-10-09

• NCT02332668

  A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  MSD Korea LTD, Seoul

  Registry updated 2026-07-06

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error